Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001329042 | SCV001520340 | uncertain significance | ANE syndrome | 2019-09-23 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV004035661 | SCV003946148 | uncertain significance | not specified | 2023-03-20 | criteria provided, single submitter | clinical testing | The c.1745G>A (p.R582Q) alteration is located in exon 16 (coding exon 16) of the RBM28 gene. This alteration results from a G to A substitution at nucleotide position 1745, causing the arginine (R) at amino acid position 582 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Undiagnosed Diseases Network, |
RCV001329042 | SCV004242185 | uncertain significance | ANE syndrome | 2019-09-23 | no assertion criteria provided | clinical testing |